Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 80151 - 80175 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Torcetrapib	Investigational	ZNF37BP	100129482	upregulated	torcetrapib results in increased expression of ZNF37BP mRNA	10q11.21	A24450
Torcetrapib	Investigational	ZNF436	80818	upregulated	torcetrapib results in increased expression of ZNF436 mRNA	1p36.12	A24450
Torcetrapib	Investigational	ZNF587	84914	upregulated	torcetrapib results in increased expression of ZNF587 mRNA	19q13.43	A24450
Torcetrapib	Investigational	ZNF616	90317	upregulated	torcetrapib results in increased expression of ZNF616 mRNA	19q13.41	A24450
Torcetrapib	Investigational	ZNF641	121274	upregulated	torcetrapib results in increased expression of ZNF641 mRNA	12q13.11	A24450
Torcetrapib	Investigational	ZNF655	79027	upregulated	torcetrapib results in increased expression of ZNF655 mRNA	7q22.1	A24450
Torcetrapib	Investigational	ZNF704	619279	upregulated	torcetrapib results in increased expression of ZNF704 mRNA	8q21.13	A24450
Torcetrapib	Investigational	ZNF740	283337	upregulated	torcetrapib results in increased expression of ZNF740 mRNA	12q13.13	A24450
Torcetrapib	Investigational	ZNF800	168850	upregulated	torcetrapib results in increased expression of ZNF800 mRNA	7q31.33	A24450
Torcetrapib	Investigational	ZNF836	162962	upregulated	torcetrapib results in increased expression of ZNF836 mRNA	19q13.33	A24450
Trabectedin	Approved Investigational	CCNA2	890	downregulated	trabectedin results in decreased expression of CCNA2 mRNA	4q27	A24452
Trabectedin	Approved Investigational	CCNB1	891	downregulated	trabectedin results in decreased expression of CCNB1 mRNA	5q13.2	A24452
Trabectedin	Approved Investigational	CCNB2	9133	downregulated	trabectedin results in decreased expression of CCNB2 mRNA	15q22.2	A24452
Trabectedin	Approved Investigational	E2F1	1869	upregulated	trabectedin results in increased expression of E2F1 mRNA	20q11.22	A24452
Tramadol	Approved Investigational	CKB	1152	downregulated	Tramadol results in decreased expression of CKB mRNA	14q32.33	A24392
Tramadol	Approved Investigational	LDHA	3939	downregulated	Tramadol results in decreased expression of LDHA mRNA	11p15.1	A24392
Tramadol	Approved Investigational	NDUFS1	4719	downregulated	Tramadol results in decreased expression of NDUFS1 mRNA	2q33.3	A24392
Tramadol	Approved Investigational	PDK3	5165	upregulated	Tramadol results in increased expression of PDK3 mRNA	Xp22.11	A24392
Tranilast	Investigational	AHR	196	upregulated	tranilast results in increased expression of AHR mRNA	7p21.1	A23387
Tranilast	Investigational	CXCR4	7852	downregulated	tranilast results in decreased expression of CXCR4 mRNA	2q22.1	A23387
Tranilast	Investigational	CYP1A1	1543	upregulated	tranilast results in increased expression of CYP1A1 mRNA	15q24.1	A23387
Tretinoin	Approved Investigational Nutraceutical	A1BG	1	downregulated	Tretinoin results in decreased expression of A1BG mRNA	19q13.43	A24453
Tretinoin	Approved Investigational Nutraceutical	AARSD1	80755	downregulated	Tretinoin results in decreased expression of AARSD1 mRNA	17q21.31	A24453
Tretinoin	Approved Investigational Nutraceutical	AASDHPPT	60496	upregulated	Tretinoin results in increased expression of AASDHPPT mRNA	11q22.3	A24453
Tretinoin	Approved Investigational Nutraceutical	AATK	9625	downregulated	Tretinoin results in decreased expression of AATK mRNA	17q25.3	A24453

Displaying entries 80151 - 80175 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability